First National Bank & Trust CO Of Newtown Abb Vie Inc. Transaction History

First National Bank & Trust CO Of Newtown

$521 Million
Q3 2024

A detailed history of First National Bank & Trust CO Of Newtown transactions in Abb Vie Inc. stock. As of the latest transaction made, First National Bank & Trust CO Of Newtown holds 13,772 shares of ABBV stock, worth $2.47 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

13,772

Previous 13,772 -0.0%

Holding current value

$2.47 Million

Previous $2.36 Million 15.11%

% of portfolio

0.52%

Previous 0.48%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $145,966 - $170,456	-943 Reduced 6.41%	13,772 $2.36 Million
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $22,374 - $25,494	-140 Reduced 0.94%	14,715 $2.68 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $34,400 - $38,742	-250 Reduced 1.66%	14,855 $2.3 Million
Q3 2023 Nov 01, 2023	SELL	$133.59 - $154.65 $73,474 - $85,057	-550 Reduced 3.51%	15,105 $2.25 Million
Q2 2023 Jul 31, 2023	SELL	$132.51 - $164.9 $28,489 - $35,453	-215 Reduced 1.35%	15,655 $2.11 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $36,152 - $41,635	-250 Reduced 1.55%	15,870 $2.53 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $6,192 - $7,873	-45 Reduced 0.28%	16,120 $2.47 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $46,193 - $57,312	-350 Reduced 2.12%	16,165 $2.62 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $21,486 - $27,186	200 Added 1.23%	16,515 $2.24 Million
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $5,320 - $6,039	50 Added 0.31%	16,315 $1.76 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $1,052 - $1,172	10 Added 0.06%	16,265 $1.83 Million
Q1 2021 May 06, 2021	SELL	$102.3 - $112.62 $192,426 - $211,838	-1,881 Reduced 10.37%	16,255 $1.76 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $39,842 - $53,791	495 Added 2.81%	18,136 $1.94 Million
Q3 2020 Nov 06, 2020	BUY	$85.91 - $100.83 $90,635 - $106,375	1,055 Added 6.36%	17,641 $1.55 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $34,263 - $45,850	467 Added 2.9%	16,586 $1.63 Million
Q4 2019 Jan 30, 2020	SELL	$72.13 - $90.25 $14,426 - $18,050	-200 Reduced 1.23%	16,119 $1.43 Million
Q2 2019 Jul 17, 2019	SELL	$65.7 - $83.98 $19,710 - $25,194	-300 Reduced 1.81%	16,319 $1.19 Million
Q4 2018 Jan 18, 2019	SELL	$77.85 - $96.01 $54,494 - $67,207	-700 Reduced 4.04%	16,619 $1.53 Million
Q3 2018 Oct 30, 2018	SELL	$88.91 - $98.84 $32,452 - $36,076	-365 Reduced 2.06%	17,319 $1.64 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $4,489 - $5,311	-50 Reduced 0.28%	17,684 $1.64 Million
Q1 2018 Apr 27, 2018	BUY	$92.01 - $123.21 $57,506 - $77,006	625 Added 3.65%	17,734 $1.68 Million
Q4 2017 Jan 17, 2018	SELL	$89.56 - $98.21 $62,692 - $68,747	-700 Reduced 3.93%	17,109 $1.66 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $1.24 Million - $1.59 Million	17,809	17,809 $1.58 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Bank & Trust CO Of Newtown, based on Form 13F filings with the SEC.

News

Stay updated on First National Bank & Trust CO Of Newtown with notifications on news.

Account

First National Bank & Trust CO Of Newtown Abb Vie Inc. Transaction History